Literature DB >> 8339277

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.

M H el Kouni1, M M el Kouni, F N Naguib.   

Abstract

Enzyme inhibition studies on extracts from human liver, mouse liver, and human placenta indicate that there are considerable differences between human and murine hepatic uridine phosphorylases (UrdPase, EC 2.4.2.3) and thymidine phosphorylases (dThdPase, EC 2.4.2.4) with regard to their specificities and roles in the phosphorolysis of natural and 5-fluoropyrimidine nucleosides. To confirm further these differences between human and murine pyrimidine nucleoside phosphorylases, UrdPase and dThdPase were isolated from human liver, mouse liver, and human placenta using diethylaminoethyl-cellulose ion exchange chromatography. The pattern of elution from the column suggests that the hydrophobicity or charges on the human enzymes at pH 8 are different from those on their murine counterparts. The amount of each enzyme present differed between tissues and species. The apparent Km, Vmax, and efficiency of catalysis (Vmax/Km) values were determined for each enzyme using uridine, thymidine, deoxyuridine, 5-fluorouridine (FUrd), 5-fluoro-2'-deoxyuridine (FdUrd), and 5'-deoxy-5-fluorouridine (5'-dFUrd) as substrates. Kinetic parameters and inhibition studies were used to ascertain the binding affinity, substrate specificity, and contributions of UrdPase and dThdPase to the phosphorolysis of the various nucleosides in the 3 tissues. The roles of UrdPase and dThdPase in human liver were quite distinct from those of their counterparts from human placenta and mouse liver. In human liver, UrdPase appears to be highly specific to uridine. Human hepatic UrdPase contributes only 15% to the cleavage of FUrd and does not contribute to the cleavage of the deoxyribosides (thymidine, deoxyuridine, FdUrd, and 5'-dFUrd). In mouse liver, UrdPase has a broader specificity as it cleaves over 85% of FUrd, 15% of FdUrd, and 25% of 5'-dFUrd. On the other hand, human hepatic dThdPase has a broader specificity than murine hepatic dThdPase. Human hepatic dThdPase cleaves all nucleosides tested including the ribosides, uridine, and FUrd. Approximately 15% of uridine and 85% of FUrd phosphorolysis in human liver is carried out by dThdPase. This contrasts with the murine hepatic dThdPase, which is more specific to deoxyribosides, as it does not contribute to the phosphorolysis of uridine, and contributes only 15% toward the cleavage of FUrd. dThdPase is the principal enzyme responsible for the phosphorolysis of 5'-dFUrd in both human and murine livers. The specificities of UrdPase and dThdPase from human placenta resembled the enzymes from the murine liver more than those from human liver. Thus, it appears that the specificities of human hepatic pyrimidine nucleoside phosphorylases are distinct from those from extrahepatic tissues.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339277

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Biosynthetic origin and mechanism of formation of the aminoribosyl moiety of peptidyl nucleoside antibiotics.

Authors:  Xiuling Chi; Pallab Pahari; Koichi Nonaka; Steven G Van Lanen
Journal:  J Am Chem Soc       Date:  2011-08-22       Impact factor: 15.419

Review 2.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

3.  Metabolites modulate the functional state of human uridine phosphorylase I.

Authors:  Yu-Ting Huang; Pei-Chin Yeh; Shih-Chun Lan; Pei-Fen Liu
Journal:  Protein Sci       Date:  2020-09-28       Impact factor: 6.725

4.  Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE.

Authors:  J Torres-Torronteras; A Gómez; H Eixarch; L Palenzuela; G Pizzorno; M Hirano; A L Andreu; J Barquinero; R Martí
Journal:  Gene Ther       Date:  2011-03-31       Impact factor: 5.250

5.  Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase.

Authors:  Phillip A Schwartz; Mathew J Vetticatt; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2010-09-29       Impact factor: 15.419

Review 6.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

7.  Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.

Authors:  Misako Haraguchi; Hiroaki Tsujimoto; Masakazu Fukushima; Itsuro Higuchi; Hideto Kuribayashi; Hideo Utsumi; Atsuo Nakayama; Yoshio Hashizume; Junko Hirato; Hiroki Yoshida; Hiromitsu Hara; Shinjiro Hamano; Hiroaki Kawaguchi; Tatsuhiko Furukawa; Kohei Miyazono; Fuyuki Ishikawa; Hideo Toyoshima; Tadashi Kaname; Masaharu Komatsu; Zhe-Sheng Chen; Takenari Gotanda; Tokushi Tachiwada; Tomoyuki Sumizawa; Kazutaka Miyadera; Mitsuhiro Osame; Hiroki Yoshida; Tetsuo Noda; Yuji Yamada; Shin-ichi Akiyama
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.

Authors:  J P Sommadossi; E M Cretton; L B Kidd; H M McClure; D C Anderson; M H el Kouni
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Authors:  Maria Lucia Valentino; Ramon Martí; Saba Tadesse; Luis Carlos López; Jose L Manes; Judy Lyzak; Angelika Hahn; Valerio Carelli; Michio Hirano
Journal:  FEBS Lett       Date:  2007-06-27       Impact factor: 4.124

10.  Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.

Authors:  A V Patterson; H Zhang; A Moghaddam; R Bicknell; D C Talbot; I J Stratford; A L Harris
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.